Sulfacetamide formulations for treatment of rosacea
AssigneeStiefel Laboratories, Inc.
InventorCharles W. Stiefel
Life of this patent
Estimating the term…
Abstract
The present invention provides improved sulfacetamide and sulfur formulations including sunscreens for the treatment of rosacea.
Claims60
A topical composition for the treatment of mammalian skin dermatoses comprising at least one sulfacetamide or a derivative thereof and at least one sunscreen.
A method of treating mammalian dermatoses by administering a topical composition comprising at least one sulfacetamide or a derivative thereof and at least one sunscreen.
The method of 16 wherein the sulfacetamide is sodium sulfacetamide.
A topical composition for the treatment of mammalian skin dermatoses comprising at least one sulfacetamide and at least one sunscreen, wherein the composition is chemically stable for more than 180 days at 25° C.
A topical composition for the treatment of mammalian skin dermatoses comprising sulfacetamide and at least one sunscreen, wherein the composition exhibits less than 10% decomposition of claim sulfacetamide or sunscreen after storage at 25° C. for 180 days.
Dependencies are inferred from the claim text.